EU | pharmaphorum

EU

News

Life science leaders sign new ‘Biotech Social Pact’ for Europe

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

The EMA's human medicines committee (CHMP) has recommended authorisation of two COVID-19 vaccines from Moderna and Pfizer/BioNTech that include sequences coding for Omicron spike protein as

News

Roctavian okay sets up another gene therapy test for Europe

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J gets first approval for multiple myeloma bispecific Tecv...

Johnson & Johnson has its first worldwide regulatory approval – in the EU – for Tecvayli, one of two much-anticipated bispecific antibodies the drugmaker has developed for patients with

News

Oncopeptides gets EU nod for myeloma drug Pepaxti ahead of U...

The European Commission has approved Oncopeptides' Pepaxti in combination with dexamethasone for multiple myeloma patients with so-called triple class refractory disease – in other words th

News

Radiology technician examens mammography test on location

AZ, Merck get EU nod for Lynparza as adjuvant breast cancer ...

The European Commission has cleared AstraZeneca and Merck & Co's Lynparza as an adjuvant treatment for breast cancer, extending its lead over would-be rivals in the PARP inhibitor class

News

AZ, Daiichi challenge Roche with EU okay for earlier use of ...

AstraZeneca and Daiichi Sankyo have claimed approval in the EU for Enhertu as a second-line therapy for HER2-positive metastatic breast cancer, moving the drug up the treatment pathway.

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

Roctavian okay sets up another gene therapy test for Europe

J&J gets first approval for multiple myeloma bispecific Tecv...

Oncopeptides gets EU nod for myeloma drug Pepaxti ahead of U...

AZ, Merck get EU nod for Lynparza as adjuvant breast cancer ...

AZ, Daiichi challenge Roche with EU okay for earlier use of ...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

EU

Editor's Picks